Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is the first oral therapy specifically designed to combat COVID-19 to be evaluated…
Pharmaceuticals, Biotechnology and Life Sciences
PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is the first oral therapy specifically designed to combat COVID-19 to be evaluated…
Novo Nordisk has expanded its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH).
Some pharmaceutical companies are donating money to support people in Ukraine and are condemning the war and violence in Ukraine.…
Abbott stands with the international community condemning the war and the violence in Ukraine against its people, and calls for peace.
The U.S. Food and Drug Administration had approved the expanded use of Opdivo, BMS’s cancer drug for patients with an aggressive form of lung cancer.
Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the…
NEWTON, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…
Holographyx has been granted a U.S. patent for its Holo-Blister product along with a European Patent for the development of…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,…
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics…